Product Development Opportunity Organogenesis recently launched ReNu, a cryopreserved amniotic suspension allograft for managing knee osteoarthritis symptoms. This innovative product presents a sales opportunity in the orthopedic market segment.
Investment Potential The recent investment of $505K by Swiss National Bank indicates confidence in Organogenesis. This financial backing can be leveraged to expand sales strategies and market reach.
Competitive Advantage With the launch of PuraPly Antimicrobial Wound Matrix, Organogenesis solidified its position in wound care. This unique product offering can drive sales growth by addressing specific healthcare needs.
Leadership Enhancement Organogenesis' strategic hiring of experienced professionals like Michele Korfin and O’Brien strengthens its corporate team. This enhanced leadership can drive sales initiatives and market penetration.
Litigation Risk Mitigation Despite facing legal challenges, Organogenesis maintains its financial position with revenues between $100M - 1B and funding of $200M. Clearing legal hurdles can ensure a stable platform for sustained sales performance.
5K
$1B
10K$1B
1$10M
93K$1B
103K$1B
3.7K$1B
66K$1B
3.3K$100M$1BOrganogenesis uses 8 technology products and services including Azure Analysis Services, Microsoft Power BI, Drupal, and more. Explore Organogenesis's tech stack below.
| Organogenesis Email Formats | Percentage |
| FLast@organo.com | 99% |
| FMiddleLast@organo.com | 1% |
| First@organogenesis.com | 53% |
| FLast@organogenesis.com | 44% |
| First.Last@organogenesis.com | 2% |
| First.MiddleLast@organogenesis.com | 1% |
Biotechnology ResearchMassachusetts, United States501-1000 Employees
Organogenesis™ is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.
Company Overview
Media & News
Funding & FinancialsOrganogenesis has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Aug 09, 2021 in the amount of $200M.
Organogenesis's revenue is in the range of $100M$1B
Funding & FinancialsOrganogenesis has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Aug 09, 2021 in the amount of $200M.
Organogenesis's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com